Arch Aesthetic Plast Surg.
2024 Jul;30(3):87-89. 10.14730/aaps.2024.01179.
Breast implant-associated squamous cell carcinoma
- Affiliations
-
- 1Department of Plastic and Reconstructive Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
- KMID: 2558217
- DOI: http://doi.org/10.14730/aaps.2024.01179
Abstract
- Breast implant-associated squamous cell carcinoma (BIA-SCC) is a rare but serious disease that originates from the lining of the breast implant capsule. Alongside BIA-anaplastic large cell lymphoma, the U.S. Food and Drug Administration issued a safety communication in 2022 regarding BIA-SCC to alert healthcare providers and patients. Although only a few cases have been reported, the high mortality and poor prognosis associated with BIA-SCC underscore the severity of the disease. This review discusses the current knowledge of BIA-SCC, including its pathogenesis, diagnostic methods, and treatment options based on reported cases.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Primary Squamous Cell Carcinoma of the Breast
- Fine Needle Aspiration Cytology of Squamous Cell Carcinoma of the Breast: Report of A Case
- Breast Metastatic Squamous Cell Carcinoma from Lung
- Pseudoangiosarcomatous Squamous Cell Carcinoma of the Face
- Squamous Cell Carcinoma Arising from Epidermal Inclusion Cyst of Breast: Imaging Findings and Literature Review
